FDA.reportPublic FDA data

Senexon

Product NDC
17856-1000
11-digit product format
178561000
Labeler code
17856
Product ID
17856-1000_9d88570f-1711-4b81-9fb4-272bd5695aa2
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides A and B
Dosage form
SYRUP
Route
ORAL
Labeler
Atlantic Biologicals Corps
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2013-02-15
Marketing end
0000-00-00
Substance
SENNOSIDES A AND B
Active strength
9 mg/5mL
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
17856-1000-12021-01-29C16284748780-1ba0f9c33-298c-a910-e053-dadaa90a0b85Senexon ®
17856-1000-52021-01-29C16284748780-1ba0f9c33-298c-a910-e053-dadaa90a0b85Senexon ®

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-1000-1Senexon10 mL in 1 CUP, UNIT-DOSESYRUP104
17856-1000-5Senexon5 mL in 1 CUP, UNIT-DOSESYRUP54

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17856-1000-1ML - Milliliter17856-10009a51ee4f-a955-4207-9d53-35cf704a6eab12015-10-02
17856-1000-5ML - Milliliter17856-1000d2e2ae32-55f2-4fe4-a60c-d79f0dc2596112015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Sennosides A and BACTIVE INGREDIENT1B5FPI42ENSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
Sennosides A and BACTIVE MOIETY1B5FPI42ENSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
COCOAINACTIVE INGREDIENTD9108TZ9KGSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3SENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
SUCROSEINACTIVE INGREDIENTC151H8M554SENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2
WATERINACTIVE INGREDIENT059QF0KO0RSENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-1000SENEXON (SENNOSIDES A AND B) SYRUP [ATLANTIC BIOLOGICALS CORPS]4Legacy NDC, 2 package rows20191019_90983cc4-04cf-4cfc-a705-5681b985e6a0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
755277SENEXON 8.8 MG in 5 mL Oral SolutionPSN90983cc4-04cf-4cfc-a705-5681b985e6a04
702311sennosides 8.8 MG in 5 mL Oral SolutionPSN90983cc4-04cf-4cfc-a705-5681b985e6a04
755277sennosides, USP 1.76 MG/ML Oral Solution [Senexon]SBD90983cc4-04cf-4cfc-a705-5681b985e6a04
702311sennosides, USP 1.76 MG/ML Oral SolutionSCD90983cc4-04cf-4cfc-a705-5681b985e6a04
755277Senexon 1.76 MG/ML Oral SolutionSY90983cc4-04cf-4cfc-a705-5681b985e6a04
755277Senexon 8.8 MG per 5 ML Oral SolutionSY90983cc4-04cf-4cfc-a705-5681b985e6a04
702311sennosides 8.8 MG per 5 mL Oral SyrupSY90983cc4-04cf-4cfc-a705-5681b985e6a04
702311sennosides, USP 26.4 MG per 15 ML Oral SolutionSY90983cc4-04cf-4cfc-a705-5681b985e6a04
702311sennosides, USP 8.8 MG per 5 ML Oral SolutionSY90983cc4-04cf-4cfc-a705-5681b985e6a04

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
17856-1000-11785610000110 mL in 1 CUP, UNIT-DOSE10 mlHistorical
17856-1000-5178561000055 mL in 1 CUP, UNIT-DOSE5 mlHistorical